Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

LILRB4 Signaling in Leukemia Cells Mediates T Cell Suppression and Tumor Infiltration

Mi Deng, PhD, Xun Gui, PhD, Jaehyup Kim, MDPhD, Junke Zheng, PhD, Ningyan Zhang, PhD, Zhiqiang An, PhD, Chengcheng Zhang, PhD

Blood (2018) 132 (Supplement 1): 5236.

https://doi.org/10.1182/blood-2018-99-120002

Published: 2018

Journal Articles

Inhibitory Receptor, gp49B1, Is Co-Expressed with c-Kit and Regulates Hematopoiesis during Development

Mi Deng, PhD, Zhigang Lu, PhD, Jaehyup Kim, MD, Chengcheng Zhang, PhD

Blood (2015) 126 (23): 4751.

https://doi.org/10.1182/blood.V126.23.4751.4751

Published: 2015

Journal Articles

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

Chelsea Hope, Samuel J. Ollar, Erika Heninger, Ellen Hebron, Jeffrey L. Jensen, Jaehyup Kim, Ioanna Maroulakou, Shigeki Miyamoto, Catherine Leith, David T. Yang, Natalie Callander, Peiman Hematti, Marta Chesi, P. Leif Bergsagel, Fotis Asimakopoulos

Blood (2014) 123 (21): 3305–3315.

https://doi.org/10.1182/blood-2014-02-554071

Published: 2014

Includes: Supplemental data

Journal Articles

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

Aditya Gupta, Jaehyup Kim, MD, Chelsea Hope, Jeff Jensen, Natalie Callander, MD, Peiman Hematti, MD, Emery H Bresnick, PhD, David C Schwartz, PhD, Fotis Asimakopoulos, MBBChir, PhD

Blood (2012) 120 (21): 2444.

https://doi.org/10.1182/blood.V120.21.2444.2444

Published: 2012

Journal Articles

Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche

Chelsea Hope, Ellen Hebron, Jaehyup Kim, MD, Jeff Jensen, Claire Flanagan, Neehar Bhatia, Catherine Leith, MBBChir, Ioanna Maroulakou, PhD, Constantine S. Mitsiades, MD, PhD, Shigeki Miyamoto, PhD, Natalie Callander, MD, Peiman Hematti, MD, Fotis Asimakopoulos, MBBChir, PhD

Blood (2012) 120 (21): 443.

https://doi.org/10.1182/blood.V120.21.443.443

Published: 2012

Journal Articles

Mesenchymal Stem Cells Convert Human Macrophages to a Novel Type of Alternatively Activated Macrophages.

Jaehyup Kim, MD, Peiman Hematti, MD

Blood (2009) 114 (22): 3632.

https://doi.org/10.1182/blood.V114.22.3632.3632

Published: 2009

NARROW

LILRB4 Signaling in Leukemia Cells Mediates T Cell Suppression and Tumor Infiltration

Inhibitory Receptor, gp49B1, Is Co-Expressed with c-Kit and Regulates Hematopoiesis during Development

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche

Mesenchymal Stem Cells Convert Human Macrophages to a Novel Type of Alternatively Activated Macrophages.

Email alerts

ASH Publications

American Society of Hematology

LILRB4 Signaling in Leukemia Cells Mediates T Cell Suppression and Tumor Infiltration

Inhibitory Receptor, gp49B1, Is Co-Expressed with c-Kit and Regulates Hematopoiesis during Development

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche

Mesenchymal Stem Cells Convert Human Macrophages to a Novel Type of Alternatively Activated Macrophages.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only